Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb;33(2):207-215.
doi: 10.1007/s11606-017-4197-5.

Advantages to Using Social-Behavioral Models of Medication Adherence in Research and Practice

Affiliations
Review

Advantages to Using Social-Behavioral Models of Medication Adherence in Research and Practice

K Rivet Amico et al. J Gen Intern Med. 2018 Feb.

Abstract

Achieving and sustaining high levels of adherence to medication regimens is essential to improving health outcomes, but continues to be a challenge for a sizable proportion of patients. Decades of research suggests that medication adherence is determined by a complex constellation of factors. Social-behavioral science research has focused on creating frameworks that identify which contextual, personal, social, or drug-related factors appear to most influence adherence. Comprehensive models of adherence propose specific structural relationships between these factors that can be used to plan for, implement, and monitor programs that seek to optimize adherence. The use of social-behavioral models offers multiple advantages in both practice and research environments; however, the breadth and depth of these models can deter many from engaging in this important exercise. To promote the use of social-behavioral frameworks and models of adherence, we provide a brief overview of the advantages in using a social-behavioral lens in adherence work, a sampling of models used in HIV medication adherence research that have high generalizability to other conditions, and practical guidance for grounding adherence promotion strategies in evidence informed by social-behavioral science research.

Keywords: HIV; adherence models; health behavior; medication adherence; social-behavioral models.

PubMed Disclaimer

Conflict of interest statement

Dr. Amico has received an education grant from Gilead Sciences through the University of Michigan. Dr. Bosworth has received consulting funds from Genentech, Sanofi, and Boehringer Ingelheim. Dr. Bosworth has also received grant funding from Sanofi, Johnson & Johnson, Takeda, and Improved Patient Outcomes. All other authors declare that they have no conflict of interest.

References

    1. Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Advances in therapy. 2005;22(4):313–356. doi: 10.1007/BF02850081. - DOI - PubMed
    1. Osterberg L, Blaschke T. Adherence to medication. The New England journal of medicine. 2005;353(5):487–497. doi: 10.1056/NEJMra050100. - DOI - PubMed
    1. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Medical care. 2005;43(6):521–530. doi: 10.1097/01.mlr.0000163641.86870.af. - DOI - PubMed
    1. Zullig LL, Granger BB, Bosworth HB. A renewed Medication Adherence Alliance call to action: harnessing momentum to address medication nonadherence in the United States. Patient preference and adherence. 2016;10:1189–1195. doi: 10.2147/PPA.S100844. - DOI - PMC - PubMed
    1. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clinic proceedings. 2011;86(4):304–314. doi: 10.4065/mcp.2010.0575. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources